Pirfenidone inhibits transforming growth factor β1-induced extracellular matrix production in nasal polyp-derived fibroblasts

American Journal of Rhinology and Allergy

Volumn 29, Issue 6, 2015, Pages 408-413

  Shin, Jae Min ^a   Park, Joo Hoo ^b   Park, Il Ho ^a   Lee, Heung Man ^a,b,c  

^a Korea University College of Medicine   (South Korea)

^b Division of Brain Korea 21 Program for Biomedical Science   (South Korea)

^c Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; FIBRONECTIN; PIRFENIDONE; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; PYRIDONE DERIVATIVE; RNA;

ADULT; ARTICLE; CELL CONTRACTION ASSAY; CELL DIFFERENTIATION; CELL ISOLATION; CELL MIGRATION; CHRONIC RHINOSINUSITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; MALE; MTT ASSAY; MYOFIBROBLAST; NOSE POLYP; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; WESTERN BLOTTING; CELL CULTURE; CELL MOTION; DRUG EFFECTS; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NASAL POLYPS; PATHOLOGY; SIGNAL TRANSDUCTION;

ADULT; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; EXTRACELLULAR MATRIX; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; MALE; NASAL POLYPS; PYRIDONES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84954161917     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2015.29.4221     Document Type: Article

References (26)

1. Pawankar R. Nasal polyposis: An update: Editorial review. Curr Opin Allergy Clin Immunol 3:1-6, 2003.
2. Shimizu S, Kouzaki H, Ogawa T, et al. Eosinophil-epithelial cell interactions stimulate the production of MUC5AC mucin and profi-brotic cytokines involved in airway tissue remodeling. Am J Rhinol Allergy 2014;28:103-109.
3. Park SJ, Jun YJ, Kim TH, et al. Increased expression of YKL-40 in mild and moderate/severe persistent allergic rhinitis and its possible contribution to remodeling of nasal mucosa. Am J Rhinol Allergy 2013; 27:372-380.
4. Nakagawa T, Yamane H, Nakai Y, et al. Comparative assessment of cell proliferation and accumulation of extracellular matrix in nasal polyps. Acta Otolaryngol Suppl 538:205-208, 1998.
5. Cho JS, Moon YM, Park IH, et al. Effects of histone deacetylase inhibitor on extracellular matrix production in human nasal polyp organ cultures. Am J Rhinol Allergy 2013;27:18-23.
6. Wang QP, Escudier E, Roudot-Thoraval F, et al. Myofibroblast accumulation induced by transforming growth factor-beta is involved in the pathogenesis of nasal polyps. Laryngoscope 107:926-931, 1997.
7. Schaefer CJ, Ruhrmund DW, Pan L, et al. Antifibrotic activities of pirfenidone in animal models. Eur Respir Rev 20:85-97, 2011.
8. Cho ME, Kopp JB. Pirfenidone: An anti-fibrotic therapy for progressive kidney disease. Expert Opin Investig Drugs 19:275-283, 2010.
9. Takeda Y, Tsujino K, Kijima T, and Kumanogoh A. Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis. Patient Prefer Adherence 8:361-370, 2014.
10. Raghu G, Johnson WC, Lockhart D, Mageto Y. Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: Results of a prospective, open-label phase II study. Am J Respir Crit Care Med 159:1061-1069, 1999.
11. Kim H, Choi YH, Park SJ, et al. Antifibrotic effect of pirfenidone on orbital fibroblasts of patients with thyroid-associated ophthalmopathy by decreasing TIMP-1 and collagen levels. Invest Ophthalmol Vis Sci 51:3061-3066, 2010.
12. Shi Q, Liu X, Bai Y, et al. In vitro effects of pirfenidone on cardiac fibroblasts: Proliferation, myofibroblast differentiation, migration and cytokine secretion. PLoS One 6:e28134, 2011.
13. Lee K, Young Lee S, Park SY, et al. Antifibrotic effect of pirfenidone on human pterygium fibroblasts. Curr Eye Res 39:680-685, 2014.
14. Lin X, Yu M, Wu K, et al. Effects of pirfenidone on proliferation, migration, and collagen contraction of human Tenon's fibroblasts in vitro. Ophthalmol Vis Sci 50:3763-3770, 2009.
15. Cho JS, Moon YM, Park IH, et al. Epigenetic regulation of myofibroblast differentiation and extracellular matrix production in nasal polyp-derived fibroblasts. Clin Exp Allergy 42:872-882, 2012.
16. Mio T, Adachi Y, Romberger DJ, et al. Regulation of fibroblast proliferation in three-dimensional collagen gel matrix. In Vitro Cell Dev Biol 32:427-433, 1996.
17. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425:577-584, 2003.
18. Yang Y, Ye Y, Lin X, et al. Inhibition of pirfenidone on TGF-beta2 induced proliferation, migration and epithlial-mesenchymal transition of human lens epithelial cells line SRA01/04. PLoS One 8:e56837, 2013.
19. Ji X, Naito Y, Weng H, et al. Renoprotective mechanisms of pirfenidone in hypertension-induced renal injury: Through anti-fibrotic and anti-oxidative stress pathways. Biomed Res 34:309-319, 2013.
20. Choi K, Lee K, Ryu SW, et al. Pirfenidone inhibits transforming growth factor-beta1-induced fibrogenesis by blocking nuclear translocation of Smads in human retinal pigment epithelial cell line ARPE-19. Mol Vis 18:1010-1020, 2012.
21. RamachandraRao SP, Zhu Y, Ravasi T, et al. Pirfenidone is renoprotective in diabetic kidney disease. J Am Soc Nephrol 20:1765-1775, 2009.
22. Daly AC, Randall RA, Hill CS. Transforming growth factor beta-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth. Mol Cell Biol 28:6889-6902, 2008.
23. Schiro JA, Chan BM, Roswit WT, et al. Integrin a2/31 (VLA-2) mediates reorganization and contraction of collagen matrices by human cells. Cell 67:403-410, 1991.
24. Klein CE, Dressel D, Steinmayer T, et al. Integrin a2/31 is up-regulated in fibroblasts and highly aggressive melanoma cells in three-dimensional collagen lattices and mediates the reorganization of collagen I fibrils. J Cell Biol 115:1427-1436, 1991.
25. Desmouliere A, Geiniz A, Gabbiani F, and Gabbiani G. Transforming growth factor-/31 induces a-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 122:103-111, 1993.
26. Rikonen T, Koivisto L, Vihinen P, and Heino J. Transforming growth factor-/3 regulates collagen gel contraction by increasing alpha 2 beta 1 integrin expression in osteogenic cells. J Biol Chem 270:376-382, 1995.